Actinogen Medical Limited (ASX:ACW)
0.0260
+0.0010 (4.00%)
Jul 29, 2025, 4:10 PM AEST
Actinogen Medical Revenue
Actinogen Medical had revenue of 9.02M AUD in the twelve months ending December 31, 2024, up 88.25% year-over-year. In the fiscal year ending June 30, 2024, Actinogen Medical had annual revenue of 9.93M with 103.18% growth.
Revenue (ttm)
9.02M
Revenue Growth
+88.25%
P/S Ratio
9.16
Revenue / Employee
1.50M
Employees
6
Market Cap
82.61M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 9.93M | 5.04M | 103.18% |
Jun 30, 2023 | 4.89M | 1.25M | 34.28% |
Jun 30, 2022 | 3.64M | 1.66M | 83.47% |
Jun 30, 2021 | 1.98M | -1.53M | -43.58% |
Jun 30, 2020 | 3.52M | -1.35M | -27.69% |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 184.58M |
Cochlear | 2.31B |
Sonic Healthcare | 9.33B |
Ramsay Health Care | 17.12B |
Telix Pharmaceuticals | 783.21M |
Ansell | 3.00B |
Mesoblast | 9.16M |
Actinogen Medical News
- 3 months ago - Actinogen provides pivotal Alzheimer's trial enrolment update and other business news - Benzinga